Crisscross enzymatic reaction between the two molecules in the active dimeric P69 form of the 2'-5' oligodenylate synthetase - PubMed (original) (raw)
. 2002 Nov 22;277(47):44760-4.
doi: 10.1074/jbc.M207126200. Epub 2002 Sep 9.
Affiliations
- PMID: 12223486
- DOI: 10.1074/jbc.M207126200
Free article
Crisscross enzymatic reaction between the two molecules in the active dimeric P69 form of the 2'-5' oligodenylate synthetase
Saumendra N Sarkar et al. J Biol Chem. 2002.
Free article
Abstract
2'-5' oligoadenylate (2-5 (A)) synthetases are major components of the antiviral pathways induced by interferons. In the presence of double-stranded RNA, they polymerize ATP to form 2-5 (A) oligomers that, in turn, activate the latent ribonuclease RNase L, causing mRNA degradation. These enzymes, unlike other nucleotidyl transferases, catalyze 2'-5', not 3'-5', phosphodiester bond formation between substrates bound to the acceptor and donor sites. Moreover, unlike other members of this extended family, the P69 isozyme of 2-5 (A) synthetase functions as a homodimer. Here, we report that the need for P69 dimerization is because of a crisscross enzyme reaction joining two substrate molecules bound to two opposite subunits. Consequently, although homodimers of mutants in the previously identified acceptor site, the donor site, or the catalytic site were inactive, selective heterodimers of the mutants were active because of subunit complementation. The catalytic site had to be present in the same subunit that contained the acceptor site, whereas the donor site had to be provided by the other subunit. These results allowed us to design a mutant protein that acted as a dominant-negative inhibitor of wt P69 but not of another isozyme of 2-5 (A) synthetase.
Similar articles
- Enzymatic characteristics of recombinant medium isozyme of 2'-5' oligoadenylate synthetase.
Sarkar SN, Bandyopadhyay S, Ghosh A, Sen GC. Sarkar SN, et al. J Biol Chem. 1999 Jan 15;274(3):1848-55. doi: 10.1074/jbc.274.3.1848. J Biol Chem. 1999. PMID: 9880569 - The nature of the catalytic domain of 2'-5'-oligoadenylate synthetases.
Sarkar SN, Ghosh A, Wang HW, Sung SS, Sen GC. Sarkar SN, et al. J Biol Chem. 1999 Sep 3;274(36):25535-42. doi: 10.1074/jbc.274.36.25535. J Biol Chem. 1999. PMID: 10464285 - Crystal structure of the 2'-specific and double-stranded RNA-activated interferon-induced antiviral protein 2'-5'-oligoadenylate synthetase.
Hartmann R, Justesen J, Sarkar SN, Sen GC, Yee VC. Hartmann R, et al. Mol Cell. 2003 Nov;12(5):1173-85. doi: 10.1016/s1097-2765(03)00433-7. Mol Cell. 2003. PMID: 14636576 - The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities.
Kristiansen H, Gad HH, Eskildsen-Larsen S, Despres P, Hartmann R. Kristiansen H, et al. J Interferon Cytokine Res. 2011 Jan;31(1):41-7. doi: 10.1089/jir.2010.0107. Epub 2010 Dec 12. J Interferon Cytokine Res. 2011. PMID: 21142819 Review. - The human 2',5'-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties.
Rebouillat D, Hovanessian AG. Rebouillat D, et al. J Interferon Cytokine Res. 1999 Apr;19(4):295-308. doi: 10.1089/107999099313992. J Interferon Cytokine Res. 1999. PMID: 10334380 Review.
Cited by
- Innate immune responses to RNA: sensing and signaling.
Luan X, Wang L, Song G, Zhou W. Luan X, et al. Front Immunol. 2024 Jan 25;15:1287940. doi: 10.3389/fimmu.2024.1287940. eCollection 2024. Front Immunol. 2024. PMID: 38343534 Free PMC article. Review. - Interferon-inducible antiviral effectors.
Sadler AJ, Williams BR. Sadler AJ, et al. Nat Rev Immunol. 2008 Jul;8(7):559-68. doi: 10.1038/nri2314. Nat Rev Immunol. 2008. PMID: 18575461 Free PMC article. Review. - A scientific journey through the 2-5A/RNase L system.
Silverman RH. Silverman RH. Cytokine Growth Factor Rev. 2007 Oct-Dec;18(5-6):381-8. doi: 10.1016/j.cytogfr.2007.06.012. Epub 2007 Jul 27. Cytokine Growth Factor Rev. 2007. PMID: 17681844 Free PMC article. Review.